Neuropharmacology and genetic aspects of CNS function
Neuropharmacology is the study of how medications affect the nervous system with the goal of creating drugs that can help people with neurological and psychiatric disorders. These include Rett syndrome, Huntington's disease, myotonic dystrophy, Single-gene mutation and fragile X syndrome. In these circumstances, the single-gene mutation results in the aberrant development and dysfunction of a few neurons in the central and peripheral nervous systems.
Related Conference of Neuropharmacology and genetic aspects of CNS function
July 25-26, 2024
4th International Conference on Biomedicine & Pharmacotherapy
Prague, Czech Republic
Neuropharmacology and genetic aspects of CNS function Conference Speakers
Recommended Sessions
- Brain and CNS Disorders
- Neuroendocrinology
- Neuroimaging and Diagnostic Techniques
- Alzheimer’s and Parkinson’s Diseases
- Brain Function and Structure
- Brain Imaging and Stimulation
- Brain Injury and Behavioural Neuroscience
- Brain Oncology Research and Pathology
- Cerebral Blood Flow and Metabolism
- Clinical Neurophysiology and Stroke
- Cognitive Neuroscience and Psychology
- Human Brain Mapping
- Molecular and cellular neurochemistry
- Neurobiology and Behaviors
- Neurogenesis
- Neuroimmunology and Neurological Infections
- Neuroinformatics and Computational Neuroscience
- Neurological Disorders and Stroke
- Neuromodulation
- Neuropharmacology and genetic aspects of CNS function
- Neuropharmacology and Neurochemistry
- Paediatric Neurology and Epilepsy
- Stem Cells Role in Neuro-Biological Treatment